Compounds > 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea
Page last updated: 2024-08-23

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Colorectal Neoplasms

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Colorectal Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boot, H; Gortzak, E; Taal, BG; Van den Hout, BM; Zoetmulder, FA1
Rodenhuis, S; Taal, BG; ten Bokkel Huinink, WW1
Alderson, D; Denton, G; Grace, RH; Hardcastle, JD; Lauri, H; Mansi, JL; Nordle, O; Smyth, JF; Wählby, S; Yosef, HM1
Wils, J1
Franklin, HR; McVie, JG; Taal, BG; ten Bokkel Huinink, WW1
Bruntsch, U; Cavalli, F; Dombernowsky, P; Gundersen, S; Pinedo, H; Renard, J; Van Glabbeke, M1

Trials

2 trial(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Colorectal Neoplasms

ArticleYear
Combination chemotherapy with tauromustine (TCNU), 5-fluorouracil and leucovorin in advanced colorectal carcinoma: a dose-finding study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Taurine

1993
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9

    Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Quality of Life; Regression Analysis; Survival Rate; Taurine; Treatment Failure

1995

Other Studies

4 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Colorectal Neoplasms

ArticleYear
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1995, Volume: 21, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine

1995
TCNU in colorectal cancer. How many patients are needed to demonstrate that a drug doesn't work?
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:2

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Nitrosourea Compounds; Survival Rate; Taurine; Treatment Failure

1996
5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Nitrosourea Compounds; Taurine

1990
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Middle Aged; Nitrosourea Compounds; Taurine

1989